Industri

Dr Vivek Jha, Head – R&D, Cilicant & Mr Dhairy Sharma, ...

FDD Conclave: Mumbai Connect | 6th March 2026 The post Dr Vivek Jha, Head – R&D...

Leadership Lens: Making R&D a boardroom conversation

FDD Conclave: Mumbai Connect | 6th March 2026 The post Leadership Lens: Making ...

Mr Jaynil Doshi, Director – Techno Commercial, Pioma Ch...

FDD Conclave: Mumbai Connect | 6th March 2026 The post Mr Jaynil Doshi, Directo...

BIRAC fuels innovation with Rs. 4,200 crore funding acr...

Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Ent...

How Much Omega-3 for Inflammation in 2026? Recommended ...

What Is Chronic Inflammation and Why Does It Matter? Chronic inflammation has be...

Congruence secures $39.5m to advance small molecule cor...

The portfolio includes programmes targeting melanocortin 4 receptor (MC4R)-defic...

Novartis to acquire SNV4818 from Synnovation

Under the contract, Novartis will pay $2bn upfront and up to $1bn in milestones ...

Eris launches weekly shot of Semaglutide starting at ₹2...

Eris Lifesciences, a leading Indian branded formulations company, today announc...

Lupin Manufacturing Solutions announces expansion of ma...

Lupin Manufacturing Solutions (LMS), a global CRDMO and subsidiary of global ph...

Zydus launches Aerolife Mini, to simplify inhaler use f...

Zydus Lifesciences, an innovation-led life-sciences company with an internation...

Glenmark Pharmaceuticals USA launches authorised generi...

Glenmark Pharmaceuticals USA announces the launch of Milnacipran Hydrochloride ...

MVS Omega-3 EU GDP Compliance: Quality and Transparency

MVS Omega-3 EU GDP Compliance: In today’s European market, consumers and partner...

Partners in progress: PPL 2026 

PPL 2026 brought together India’s pharma packaging ecosystem to explore how col...

R1 Therapeutics raises $77.5m to progress AP306 for hyp...

The company also secured an exclusive global licence for the development and com...

FDA issues CRL to Aldeyra’s reproxalap drug application

This CRL stated that the application lacks substantial evidence of efficacy from...

Zydus and Torrent Pharma sign licensing agreement to co...

Zydus Lifesciences, an innovation-led global life-sciences company and Torrent ...